PDUFA Draft Bill Would Broaden FDA’s Mission, Make Guidance Development More Public
This article was originally published in The Pink Sheet Daily
FDA would be tasked with protecting public health while promoting economic growth and job creation under a discussion draft from the House authorizing committee. Draft Guidances would be voided if not finalized within a year under the proposal.
You may also be interested in...
House and Senate committee user fee bill mark-ups approaching, but drafts have differences in drug shortage, supply chain security and other proposed policy changes to reconcile.
Provision allowing generic drug fee waivers in shortage situations was removed in new House user fee draft, but proposals for a new antibacterial approval pathway and breakthrough designation were not included.
Proposal would require shortage consideration before FDA issues an enforcement action, which could ensure enforcement and shortage staff continue talking.